
Arlan Biotech provides a Generative AI-powered SaaS platform that speeds up discovery of nanobody VHH sequences. It generates optimized VHH sequences targeting specific protein epitopes within minutes and can create custom libraries for phage or yeast display. Core technologies include Generative AI, VHH sequence generation, and nanobody design. The product is aimed at biotechnology companies needing rapid antibody discovery workflows and library construction. This platform scales to enable broader VHH discovery and development in the biotech market.

Arlan Biotech provides a Generative AI-powered SaaS platform that speeds up discovery of nanobody VHH sequences. It generates optimized VHH sequences targeting specific protein epitopes within minutes and can create custom libraries for phage or yeast display. Core technologies include Generative AI, VHH sequence generation, and nanobody design. The product is aimed at biotechnology companies needing rapid antibody discovery workflows and library construction. This platform scales to enable broader VHH discovery and development in the biotech market.